The E7 protein of human papillomavirus (HPV) type 16 expressed by recombinant vaccinia virus can be used for detection of antibodies in sera from cervical cancer patients

Journal of Virological Methods

Volumn 62, Issue 1, 1996, Pages 81-85

  Nindl, Ingo ^a   Gissmann, Lutz ^b   Fisher, Susan G ^b   Benitez Bribiesca, Luis ^c   Berumen, Jaime ^c   Muller, Martin ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

cervical cancer; human papillomavirus; linear and discontinuous epitopes; serology; vaccinia virus

Indexed keywords

SYNTHETIC PEPTIDE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MEXICO; PAPILLOMA VIRUS; PRIORITY JOURNAL; SERODIAGNOSIS; UTERINE CERVIX CANCER; VIRUS DETECTION;

CANCER VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0030272893     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(96)02084-8     Document Type: Article

References (18)

1. Falkner, F.G. and Moss, B. (1988) Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62, 1849-1854.
2. Greenfield, I., Nickerson, J., Penman, S. and Stanley, M. (1991) Human papillomavirus 16 E7 protein is associated with the nuclear matrix. Proc. Natl. Acad. Sci. USA 88/24, 11217-11221.
3. Jha, P.K., Beral, V., Peto, J., Hack, S., Hermon, C., Deacon, J., Mant, D., Chilvers C., Vessey, M.P., Pike, M.C. et al. (1993) Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 341/8853, 1116-1118.
4. Jochmus-Kudielka, I., Schneider, A., Braun, R., Kimmig, R., Koldovsky, U., Schneweis, K.E., Seedorf, K. and Gissmann, L. (1989) Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J. Natl. Cancer Inst. 81, 1698-1704.
5. Kanda, T., Onda, T., Zanma, S., Yasugi, T., Furuno, A., Watanabe, S., Kawana, T., Sugase, M., Ueda, K., Sonoda, T., Suzuki, S., Yamashiro, T., Yoshikawa, H. and Yoshiike, K. (1992) Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer. Virology 190, 724-732.
6. Krchnak, V., Vagner, J., Suchankova, A., Krcmar, M., Ritterova, L. and Vonka, V. (1990) Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. J. Gen. Virol. 71, 2719-2724.
7. Mackett, M., Smith, G.L. and Moss, B. (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49, 857-864.
8. Mann, V.M., de-Lao, S.L., Brenes, M., Brinton, L.A., Rawls, J.A., Green, M., Reeves, W.C. and Rawls, W.E. (1990) Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Res. 50/24. 7815-7819.
9. Müller, M., Viscidi, R.P., Sun, Y., Guerrero, E., Hill. P.M., Shah, F., Bosch F.X., Munoz, N., Gissmann, L. and Shah, K.V. (1992) Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 187, 508-514.
10. Nindl, I., Benitez Bribiesca, L., Berumen, J., Farmanara, N., Fisher, S., Gross, G., Lopez Carillo, L., Müller, M., Tommasino, M. and Vazquez Curiel, A. (1994) Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients. Arch. Virol. 137, 341-353.
11. Oltersdorf, T., Seedorf, K., Röwekamp, W. and Gissman, L. (1987) Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies. J. Gen. Virol. 68, 2933-2938.
12. Panicali, D. and Paoletti, E. (1992) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 79, 4927-4931.
13. Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. and zur Hausen, H. (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
14. Seedorf, K., Oltersdorf, T., Krammer, G. and Röwekamp, W. (1987) Identification of early proteins of the human papillomavirus type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J. 6, 139-144.
15. Stacey, S.N., Ghosh, A., Bartholomew, J.S., Tindle, R.W., Stern, P.L., Mackett, M. and Arrand, J.R. (1992) Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients. J. Med. Virol. 40, 14-21.
16. Viscidi, R.P., Sun, Y. and Shah, K.V. (1992) Immune response to linear epitopes of human papillomaviruses infecting the genital tract. Clin. Immunol. 12, 97-101.
17. Viscidi, R.P., Sun, Y., Tsuzaki, B., Bosch, F.X., Munoz, N. and Shah, K.V. (1993) Serological response in human papillomavirus-associated invasive cervical cancer. Int. J. Cancer 55, 780-784.
18. zur Hausen, H. (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Opinion Genet. Dev. 186, 131-156.